Central Nervous System Drugs Market Research Reports
Title | published | price | |
---|---|---|---|
Peripheral Nerve Injury Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key PlayersBy Global Markets Direct "...... ine landscape.
The report provides comprehensive information on the therapeutics under development for Peripheral Nerve Injury, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administrati......" | 02-May-2022 | $2000 | |
Alzheimer's Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 UpdateBy Global Markets Direct "...... oA, Molecule Type and Key Players, 2022 Update, provides an overview of the Alzheimer's Disease (Central Nervous System) pipeline landscape.
Alzheimer's disease is a progressive, degenerative condition causing damage to the memory and be......" | 01-Apr-2022 | $2500 | |
Cluster Headache Syndrome (Cluster Headache) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 UpdateBy Global Markets Direct "...... pment by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Cluster Headache Syndrome (Central Nervous System) pipeline landscape.
Cluster headache is pain that occurs along one side of the ......" | 31-Mar-2022 | $2000 | |
Complex Regional Pain Syndrome (Sympathetic Reflex Dystrophy/Reflex Sympathetic Dystrophy) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 UpdateBy Global Markets Direct "...... de Complex Regional Pain Syndrome - Drugs in Development by Stages, Target, MoA, RoA, Mol, provides an overview of the Complex Regional Pain Syndrome (Central Nervous System) pipeline landscape.
Complex regional pain syndrome (CRPS) is a......" | 31-Mar-2022 | $2000 | |
Drug Addiction Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 UpdateBy Global Markets Direct "...... le Type and Key Players, 2022 Update, provides an overview of the Drug Addiction (Central Nervous System) pipeline landscape.
Drug addiction, also called substance dependence or chemical dependency, is a disease that is characterized by ......" | 31-Mar-2022 | $2000 | |
Encephalomyelitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 UpdateBy Global Markets Direct "...... Molecule Type and Key Players, 2022 Update, provides an overview of the Encephalomyelitis (Central Nervous System) pipeline landscape.
Encephalomyelitis is an inflammation of the brain and spinal cord. Encephalomyelitis can be caused by ......" | 31-Mar-2022 | $2000 | |
Dementia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 UpdateBy Global Markets Direct "...... Key Players, 2022 Update, provides an overview of the Dementia (Central Nervous System) pipeline landscape.
Dementia is the loss of mental functions such as thinking, memory, and reasoning that is severe enough to interfere with a person......" | 31-Mar-2022 | $2500 | |
Epilepsy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 UpdateBy Global Markets Direct "...... Key Players, 2022 Update, provides an overview of the Epilepsy (Central Nervous System) pipeline landscape.
Epilepsy is a neurological disorder characterized by the transmission of abnormal signals produced by a group of neurons in the b......" | 31-Mar-2022 | $2500 | |
Batten Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 UpdateBy Global Markets Direct "...... le Type and Key Players, 2022 Update, provides an overview of the Batten Disease (Central Nervous System) pipeline landscape.
Batten disease, a rare genetic disorder, belongs to a group of progressive degenerative neurometabolic disorder......" | 31-Mar-2022 | $2000 | |
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 UpdateBy Global Markets Direct "...... ing Polyneuropathy (CIDP) - Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) (Central Nervous System) pipeline landscape......" | 31-Mar-2022 | $2000 | |
|